Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Safety and efficacy of pegylated recombinant human granulocyte colony-stimulating factor during concurrent chemoradiotherapy for small-cell lung cancer: a retrospective, cohort-controlled trial

Fig. 1

Blood count differences between the two groups. CCRT: concurrent chemoradiotherapy; WBC: white blood cell; ANC: absolute neutrophil count; RBC: red blood cell; PLT: platelet; HB: hemoglobin. * Factors with statistical significance: ns: no significance; *: p < 0.05; **: p < 0.01; ***: p < 0.001

Back to article page